Stimcell Energetics Inc. (STME) intrinsic value & 10-year financials

Stimcell Energetics Inc. (STME) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.23
Revenue (FY2025)
—
Revenue growth (10-yr CAGR)
-30.9%
ROIC (10-yr avg)
70.0%
Free cash flow (FY2025)
—

STME 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$566.3K — — — 54.6%
FY2024 $0 -$142.5K — — — 8.9%
FY2023 $2.8K -$495.0K — — — 22.5%
FY2022 — -$697.4K — -$450.6K — 38.9%
FY2021 — -$910.8K — -$562.0K — 58.8%
FY2020 $95.8K -$1.1M — -$928.3K — 66.4%
FY2019 $0 -$906.0K — -$309.5K — 63.7%
FY2018 — -$1.5M — -$449.4K — 137.9%
FY2017 $6.2K -$1.2M — -$864.3K — 96.8%
FY2016 $36.6K -$2.1M — -$640.4K — 151.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Stimcell Energetics Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Stimcell Energetics Inc. has earned high returns on invested capital, averaging 55.0% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Stimcell Energetics Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Stimcell Energetics Inc. is modeled at -30.9% normalized earnings growth with a 5.1% bond-yield adjustment.

STME stock: frequently asked questions

What is STME's return on invested capital?

Average ROIC over the last 10 fiscal years was 70.0%, and average return on equity was 70.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this STME data come from?

From Stimcell Energetics Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Apr 10, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks